Skip to content

Overall Survival and Associated Clinical Factors in Advanced Gastric Cancer: A Retrospective Analysis from the Maharat Nakhon Ratchasima Hospital Cancer Registry

Overall Survival and Associated Clinical Factors in Advanced Gastric Cancer: A Retrospective Analysis from the Maharat Nakhon Ratchasima Hospital Cancer Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20241001002
Enrollment
318
Registered
2024-10-01
Start date
2018-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Gastric Cancer Gastric Neoplasms, Stomach Cancer, Survival Analysis, Retrospective Studies, Risk Factors, Prognosis, Chemotherapy, Malnutrition, Advanced-Stage Cancer

Interventions

This group includes patients diagnosed with Stage III or Stage IV gastric cancer who are ineligible for surgery or radiation. Chemotherapy is optional for these patients, and various clinical factors,
Supportive Care
Advanced Gastric Cancer Patients

Sponsors

Department of Medicine, Maharat Nakhon Ratchasima Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosed with advanced-stage gastric cancer (Stage III or IV). Treated at Maharat Nakhon Ratchasima Hospital. Ineligible for surgery or radiation. Diagnosed between January 1, 2018, and December 31, 2023.

Exclusion criteria

Exclusion criteria: Patients with incomplete medical records. Patients lost to follow-up immediately after diagnosis.

Design outcomes

Primary

MeasureTime frame
1-Year Overall Survival 1 year after diagnosis Kaplan-Meier survival analysis

Secondary

MeasureTime frame
Median Overall Survival From diagnosis to death or last follow-up Kaplan-Meier survival analysis, with median survival calculated from diagnosis to death or last follow-up,Association between Clinical Factors and Survival Continuous analysis over the follow-up period (minimum 12 months) Logistic regression to identify the association between clinical factors and survival

Countries

Thailand

Contacts

Public ContactJirawat Thanestada

Maharat Nakhon Ratchasima hospital

jthanestada@gmail.com0824924154

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026